argus

JUBILANT PHARMOVA LIMITED

NSE: JUBLPHARMAINE700A0103314,422 Cr

Timeline

Time (IST)TypeMEventSrc
08 Oct, 08:21 pmJubilant Pharmova Limited has informed the Exchange about General Updates- Submission of communication email sent to shareholders whose dividend(s) remainsunpaid pursuant to "Saksham Niveshak - 100 Days Campaignnse
04 Oct, 11:54 pmJubilant Pharmova Limited has informed the Exchange about General Updates - Submission of second communication sent to shareholders relating to notice of transfer of equity shares to Investor Education and Protection Fund Authoritynse
01 Oct, 01:19 pmJubilant Pharmova Limited has informed the Exchange about General Updates - Allotment of Optionally Convertible Redeemable Non-Cumulative Preference Shares (OCRPS) by Jubilant Biosys Limited, a wholly owned subsidiary company.nse
23 Sept, 11:40 amJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Managementbse
23 Sept, 11:40 amJubilant Pharmova Limited has informed the Exchange regarding Appointment of Mr. Arun Kumar Sharma as Chief Financial Officer of the company w.e.f. October 01, 2025.nse
23 Sept, 11:38 amJubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Outcome Of Board Meeting Held On September 23, 2025bse
23 Sept, 11:38 amAppointment of CFO of the Companynse
20 Sept, 08:31 pmJubilant Pharmova Limited has informed the Exchange about General Updates-Jubilant Pharmova announces Completion of Pharmacovigilance Inspectionby the USFDA with No Observationsnse
12 Sept, 08:02 pmJubilant Pharmova Ltd - 530019 - Reminder Email Sent To Shareholders Intimating About The 100 Days Campaignbse
12 Sept, 07:59 pmJubilant Pharmova Limited has informed the Exchange about General Updatesnse
02 Sept, 11:43 pmJubilant Pharmova Limited has informed the Exchange about General Updates- Receipt of Orders passed by the Additional Commissioner Central Tax (Appeals), Mysurunse
02 Sept, 11:42 pmJubilant Pharmova Ltd - 530019 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Receipt Of Orders Passed By The Additional Commissioner Central Tax (Appeals), Mysurubse
01 Sept, 11:45 pmJubilant Pharmova Limited has informed the Exchange about General Updates- Completion of Sale and Transfer of API Businessnse
01 Sept, 11:42 pmJubilant Pharmova Ltd - 530019 - Disclosure Under Regulation 30 - Completion Of Sale And Transfer Of API Businessbse
01 Sept, 02:05 pmJubilant Pharmova Limited has informed the Exchange about change in Managementnse
01 Sept, 02:03 pmJubilant Pharmova Limited has informed the Exchange regarding Resignation of Dr. Ramakrishnan Arul as Executive Director of the company w.e.f. August 31, 2025.nse
01 Sept, 01:54 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Managementbse
01 Sept, 01:50 pmJubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse